NCPA - National Center for Policy Analysis

Daily Policy Digest

Health Issues

What Holds Back Consumer-Driven Health Plans?

CHDPs became available in 2005. However, they only appear to cover a little over one quarter of employed people or their dependents who are enrolled in their benefits. How can such a small proportion of people be enrolled in CDHPs after over a decade of evidence supporting the case that they cut the rate of growth of health spending?, asks NCPA Senior Fellow John R. Graham...

How Federal Regulations Hiked EpiPen Prices

People with severe allergies and asthma often carry an epinephrine auto-injector or have one readily available at all times. The most common model by far is the EpiPen, which enjoys an 85 percent market share. The price of the EpiPen, preloaded with the generic drug epinephrine, has increased by more than 400 percent in less than a decade, writes NCPA Senior Fellow Devon Herrick...

Everybody Gets A Medal: Budget Busting "Incentives" in Medicare Reform

Last April, the Centers for Medicare & Medicaid Services published a new rule in accord with the seriously flawed 2015 Medicare reform law. About half of doctors would be rewarded for meeting quality incentives. In the final rule, published this month, 95 percent of doctors will be rewarded, writes NCPA Senior Fellow John R. Graham...

California's Surprise Medical Bill Law Papers Over A Systemic Problem

Insured patients who go into hospital for scheduled surgery are often shocked to find they owe bills well beyond what they expected to pay, especially if they understood the hospital and surgeon to be in their health plan's network. A new law in California will regulate prices out-of-network specialists charge. It addresses the symptoms of the problem, but not the cause, writes NCPA Senior Fellow John R. Graham...

Mixed News on Generic Drug Approvals

The Food and Drug Administration's Office of Generic Drugs has executed 651 approvals in 2016, the largest number of approvals in a fiscal year in (at least) the last 8 years. The bad news is that OGD received a total of 853 applications in FY 2016 which is 202 more than it approved. The regulatory backlog remains, writes NCPA Senior Fellow John R. Graham...

Government and the Cost of Dental Care

Dentistry looks like a consumer-driven market: Insurance is far less prevalent in dentistry than in medicine, and most dental care is routine and preventive. Yet, costs of dental care have risen at the same rate as those of other health care, not at the rate of other consumer goods and services. The problem lies on the supply side, with restrictive licensing, writes NCPA Senior Fellow John R. Graham...

Consumer-Driven Health Plans Reduce Spending One Eighth

The Health Care Cost Institute has released its analysis of claims data for the years 2010 through 2014, comparing consumer-driven health plans with traditional health plans. CDHPs shift payment from third-party bureaucracies (that is, insurers) back to patients directly. The results continue to impress, cutting spending by one eighth, writes NCPA Senior Fellow John R. Graham...

Who Benefits From The "Right to Try" Experimental Medicines?

Thirty-one states have now passed laws giving patients the "Right to Try" experimental medicines. However, they do not appear to be getting the medicines. There are two problems and one solution, according to NCPA Senior Fellow John R. Graham...

A Modest Proposal to Reduce the Price of EpiPens

Posturing politicians on Capitol Hill conducted a hearing, in which they grilled Heather Bresch, CEO of Mylan. N.V., which makes EpiPens. Prices of EpiPens have skyrocketed in the last few years. The politicians ignored a fundamental reform to the FDA's powers, which would quickly reduce prices of EpiPen, writes NCPA Senior Fellow John R. Graham...

A Health Care Legacy Moonshot for Obama

President Obama has an opportunity to win a positive legacy in health care. Legislation modernizing the FDA, the 21st Century Cures Act, is being fumbled inches away from the Congressional end zone. Presidential leadership is needed, writes NCPA Senior Fellow John R. Graham...


« Newer « 3 4 5 6 7 8 9 10  Older »